May 3, 03:05 PM

FTC Extends Review of Novo Holdings' $16.5 Billion Catalent Acquisition

The U.S. Federal Trade Commission (FTC) has issued a second request for more information regarding the $16.5 billion acquisition of Catalent by Novo Nordisk's parent company, Novo Holdings. This move, part of an extended antitrust review, could delay the deal by an additional 30 days. The request reflects the FTC's ongoing scrutiny of the transaction amid concerns from other pharmaceutical groups and contract manufacturers.

#FTC #Catalent #Novo Nordisk #Novo Holdings

Written with ChatGPT (GPT-4).

Sources

Michael Albert, MD@MichaelAlbertMD
2 years ago
FTC wants more information on Novo-Catalent deal in antitrust review https://t.co/OVgujnJEAj
Endpoints News@endpts
2 years ago
The Federal Trade Commission has extended its antitrust review of Novo Holdings’ $16.5 billion purchase of Catalent by potentially another 30 days as it requests additional information. https://t.co/WaaDXofM4B
Reuters@Reuters
2 years ago
US FTC seeks more information on Novo Nordisk parent-Catalent deal https://t.co/gPTYCIuwWU https://t.co/vrJv5qDkHy

Additional media

Image #1 for story ftc-extends-review-novo-holdings-16-5-billion-catalent

FTC Extends Review of Novo Holdings' $16.5 Billion Catalent Acquisition

Sources

Additional media

Similar Stories